TY  - GEN
AU  - Pryse-Phillips,William
TI  - Newer long-term treatments for multiple sclerosis
SN  - 0303-8467
PY  - 2002///1008
KW  - Adjuvants, Immunologic
KW  - therapeutic use
KW  - Adrenal Cortex Hormones
KW  - Antibody Formation
KW  - Combined Modality Therapy
KW  - Cost-Benefit Analysis
KW  - Disease Progression
KW  - Ethics, Medical
KW  - Glatiramer Acetate
KW  - Health Care Costs
KW  - Humans
KW  - Immunoglobulins, Intravenous
KW  - Immunosuppressive Agents
KW  - Interferon beta-1a
KW  - Interferon beta-1b
KW  - Interferon-beta
KW  - Multiple Sclerosis
KW  - complications
KW  - Peptides
KW  - Plasmapheresis
KW  - Prognosis
KW  - Quality of Life
KW  - Recurrence
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1016/s0303-8467(02)00050-1
ER  -